Ogivri (Trastuzumab)
trastuzumab 150 mg injection, 1 vial · INJECTION · PBS code 4632T
STREAMLINEDWhat it costs
AU$105.18 PBS-determined price per pack
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2019-08-01.
- • Repeats: 0.
- • PBS program: TZ.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Early HER2 positive breast cancer
Initial treatment (weekly regimen)
Patient must have undergone surgery (adjuvant) or be preparing for surgery (neoadjuvant); AND
The treatment must not be used in a patient with a left ventricular ejection fraction (LVEF) of less than 45% and/or with symptomatic heart failure; AND
Patient must not receive more than 52 weeks of combined PBS-subsidised and non-PBS-subsidised therapy; or
Patient must not receive more than 52 weeks of combined trastuzumab and trastuzumab emtansine therapy if adjuvant trastuzumab emtansine therapy has been discontinued due to intolerance.
HER2 positivity must be demonstrated by in situ hybridisation (ISH).
Cardiac function must be tested by echocardiography (ECHO) or multigated acquisition (MUGA), prior to initiating treatment with this drug for this condition.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 2
Increased maximum amounts may only be authorised where a patient's weight is greater than 125 kg.
Sponsor: Sandoz Pty Ltd ABN 60 075 449 553
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.